Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for MediWound (MDWD) over the last 10 years, with Q3 2025 value amounting to $94.4 million.

  • MediWound's Liabilities and Shareholders Equity rose 2634.54% to $94.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $303.9 million, marking a year-over-year increase of 1651.04%. This contributed to the annual value of $73.5 million for FY2024, which is 1058.85% up from last year.
  • Latest data reveals that MediWound reported Liabilities and Shareholders Equity of $94.4 million as of Q3 2025, which was up 2634.54% from $67.0 million recorded in Q2 2025.
  • MediWound's Liabilities and Shareholders Equity's 5-year high stood at $94.4 million during Q3 2025, with a 5-year trough of $19.7 million in Q4 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $62.4 million (2024), whereas its average is $52.1 million.
  • In the last 5 years, MediWound's Liabilities and Shareholders Equity plummeted by 3645.32% in 2021 and then soared by 20496.54% in 2023.
  • Over the past 5 years, MediWound's Liabilities and Shareholders Equity (Quarter) stood at $19.7 million in 2021, then surged by 153.32% to $50.0 million in 2022, then soared by 32.88% to $66.5 million in 2023, then grew by 10.59% to $73.5 million in 2024, then rose by 28.47% to $94.4 million in 2025.
  • Its Liabilities and Shareholders Equity was $94.4 million in Q3 2025, compared to $67.0 million in Q2 2025 and $69.0 million in Q1 2025.